The results showed that VEGF was down-regulated, blood vessel growth was blocked, and colon cancer liver metastasis was inhibited, suggesting that CBS could be used as a therapeutic target for colon cancer liver metastasis (45). The gene discussed is VEGFA; the disease is colonic neoplasm.